Thus, in this case, in order to evaluate the insulin-sensitizing response of testosterone, a prolonged OGTT was performed with glucose and insulin measurements at 0, 30, 60, 120, 180 and 240 minutes before and after the administration of TU. In addition, complete remission of DM2, risk reduction of cardiovascular disease and mortality was reported with TU treatment 25–28. Our patient had several cardiovascular risk factors, including HTN, DM2, DLD and obesity, the most commonly reported comorbidities in patients with this type of karyotypic abnormality. Men with KS have an increased mortality risk, probably due to their higher predisposition to develop congenital malformations, cardiovascular disease and endocrine-metabolic disorders, compared to age-matched controls . Vildagliptin was discontinued and the patient was asked to undergo a prolonged oral glucose tolerance test (OGTT) with blood glucose measurements at various timepoints, prior to and 48 hours after the next administration of testosterone. Low testosterone and diabetes can both cause problems with sexual health, especially in men. When both conditions are present, the heart must work harder to pump blood through the body. Research shows that men with low T are more likely to have high blood pressure, high cholesterol, and a higher risk of heart attacks. Future research directions may focus on an evaluation of an alternative of use of TRT in subjects with diabetes, even defining different daytime to take this therapy, depending by glycemic values of the subjects, leading to a "tailor made" treatment. Finally, the increase in total testosterone after 12 weeks appeared rather moderate, and this may have influenced the outcome; this could be due to the phenotypic features of our population, characterized by overweight/obesity and mainly hypogonadotropic hypogonadism. In addition, a long-term real-world evidence study showed that TRT with undecanoate injections promoted the remission of DM in one-third of the patients and the improvement of glycemic control in the remaining subjects . We clearly are seeing many more people who are taking high levels of testosterone in gel form because they tell themselves it’s one dose and they apply it all over. Potential mechanisms include resistance to the normal stimulatory effects of insulin on the hypothalamic-pituitary-gonadal axis, suppression by pro-inflammatory cytokines, and high leptin levels. Reassuringly, there was no evidence of an increased risk of cardiovascular disease, although a slight increased risk of venous thromboembolism and atrial fibrillation was observed. Men with hypogonadal testosterone levels were twice as insulin resistant as eugonadal controls. We showed a positive correlation between serum testosterone levels and insulin sensitivity in men across the full spectrum of glucose tolerance. Low testosterone is linked to an increased risk of developing type 2 diabetes. Low testosterone levels can result from several factors, such as aging, obesity, and certain medical conditions. When testosterone levels drop, it can cause various symptoms, such as fatigue, depression, and reduced sexual function. One of the biggest concerns for people with both low testosterone and diabetes is the risk to their heart and blood vessels. When testosterone levels are low, men can lose bone mass, which can lead to weaker bones or even osteoporosis, a condition that makes bones more likely to break. Men who were taking medication known to affect androgen production and/or testosterone were likewise excluded. Increasing patient age and increasing duration of prior exogenous testosterone use both significantly reduced the likelihood of reaching the 5 million TMSC benchmark. Older meta-analyses from 2007 and 2005 similarly demonstrated no impact of testosterone on lipid profiles.312, 327 No differences were identified in total cholesterol, low-density lipoproteins, or HDL. A second large RCT by Snyder et al.319 used the Functional Assessment of Chronic Illness Therapy-Fatigue scales (range 0-52) in 474 men treated with testosterone for 12 months.
